How Natalizumab Binds and Antagonizes α4 Integrins

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2013 Sep 20

PMID 24047894

Citations 51

Authors

Yamei Yu

Thomas Schurpf

Timothy A Springer

Affiliations

Soon will be listed here.

Abstract

Natalizumab antibody to α4-integrins is used in therapy of multiple sclerosis and Crohn's disease. A crystal structure of the Fab bound to an α4 integrin β-propeller and thigh domain fragment shows that natalizumab recognizes human-mouse differences on the circumference of the β-propeller domain. The epitope is adjacent to but outside of a ligand-binding groove formed at the interface with the β-subunit βI domain and shows no difference in structure when bound to Fab. Competition between Fab and the ligand vascular cell adhesion molecule (VCAM) for binding to cell surface α4β1 shows noncompetitive antagonism. In agreement, VCAM docking models suggest that binding of domain 1 of VCAM to α4-integrins is unimpeded by the Fab, and that bound Fab requires a change in orientation between domains 1 and 2 of VCAM for binding to α4β1. Mapping of species-specific differences onto α4β1 and α4β7 shows that their ligand-binding sites are highly conserved. Skewing away from these conserved regions of the epitopes recognized by current therapeutic function-blocking antibodies has resulted in previously unanticipated mechanisms of action.

Citing Articles

Human ITGAV variants are associated with immune dysregulation, brain abnormalities, and colitis.

Ghasempour S, Warner N, Guan R, Rodari M, Ivanochko D, Whittaker Hawkins R J Exp Med. 2024; 221(12).

PMID: 39526957 PMC: 11554753. DOI: 10.1084/jem.20240546.

Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis.

Foley J, Defer G, Zhovtis Ryerson L, Cohen J, Arnold D, Butzkueven H Neurol Neuroimmunol Neuroinflamm. 2024; 11(6):e200321.

PMID: 39393045 PMC: 11488827. DOI: 10.1212/NXI.0000000000200321.

Structural insights into the molecular recognition of integrin αVβ3 by RGD-containing ligands: The role of the specificity-determining loop (SDL).

Mariasoosai C, Bose S, Natesan S bioRxiv. 2024; .

PMID: 39386435 PMC: 11463590. DOI: 10.1101/2024.09.23.614545.

T cell trafficking in human chronic inflammatory diseases.

Giovenzana A, Codazzi V, Pandolfo M, Petrelli A iScience. 2024; 27(8):110528.

PMID: 39171290 PMC: 11338127. DOI: 10.1016/j.isci.2024.110528.

Androgen deprivation therapy exacerbates Alzheimer's-associated cognitive decline via increased brain immune cell infiltration.

Zhang C, Aida M, Saggu S, Yu H, Zhou L, Rehman H Sci Adv. 2024; 10(25):eadn8709.

PMID: 38905345 PMC: 11192088. DOI: 10.1126/sciadv.adn8709.

References

Murzin A . Structural principles for the propeller assembly of beta-sheets: the preference for seven-fold symmetry. Proteins. 1992; 14(2):191-201. DOI: 10.1002/prot.340140206. View

Schiffer S, Hemler M, Lobb R, Tizard R, Osborn L . Molecular mapping of functional antibody binding sites of alpha 4 integrin. J Biol Chem. 1995; 270(24):14270-3. DOI: 10.1074/jbc.270.24.14270. View

Davis I, Leaver-Fay A, Chen V, Block J, Kapral G, Wang X . MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 2007; 35(Web Server issue):W375-83. PMC: 1933162. DOI: 10.1093/nar/gkm216. View

Shapiro R, Plavina T, Schlain B, Pepinsky R, Garber E, Jarpe M . Development and validation of immunoassays to quantify the half-antibody exchange of an IgG4 antibody, natalizumab (Tysabri®) with endogenous IgG4. J Pharm Biomed Anal. 2011; 55(1):168-75. DOI: 10.1016/j.jpba.2011.01.006. View

Polman C, OConnor P, Havrdova E, Hutchinson M, Kappos L, Miller D . A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006; 354(9):899-910. DOI: 10.1056/NEJMoa044397. View

Pulido R, Elices M, Campanero M, Osborn L, Schiffer S, Garcia-Pardo A . Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct alpha 4 epitopes. J Biol Chem. 1991; 266(16):10241-5. View

Xiao T, Takagi J, Coller B, Wang J, Springer T . Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature. 2004; 432(7013):59-67. PMC: 4372090. DOI: 10.1038/nature02976. View

Thomas S, Baumgart D . Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis. Inflammopharmacology. 2011; 20(1):1-18. DOI: 10.1007/s10787-011-0104-6. View

Springer T, Dustin M . Integrin inside-out signaling and the immunological synapse. Curr Opin Cell Biol. 2011; 24(1):107-15. PMC: 3294052. DOI: 10.1016/j.ceb.2011.10.004. View

10.

Davis L, Bednarczyk J, McIntyre B, Lipsky P . Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol. 1990; 145(3):785-93. View

11.

Li S, Wang H, Peng B, Zhang M, Zhang D, Hou S . Efalizumab binding to the LFA-1 alphaL I domain blocks ICAM-1 binding via steric hindrance. Proc Natl Acad Sci U S A. 2009; 106(11):4349-54. PMC: 2657446. DOI: 10.1073/pnas.0810844106. View

12.

Karplus P, Diederichs K . Linking crystallographic model and data quality. Science. 2012; 336(6084):1030-3. PMC: 3457925. DOI: 10.1126/science.1218231. View

13.

Luo B, Strokovich K, Walz T, Springer T, Takagi J . Allosteric beta1 integrin antibodies that stabilize the low affinity state by preventing the swing-out of the hybrid domain. J Biol Chem. 2004; 279(26):27466-71. DOI: 10.1074/jbc.M404354200. View

14.

Yu Y, Zhu J, Mi L, Walz T, Sun H, Chen J . Structural specializations of α(4)β(7), an integrin that mediates rolling adhesion. J Cell Biol. 2012; 196(1):131-46. PMC: 3255974. DOI: 10.1083/jcb.201110023. View

15.

Sidhu S . Antibodies for all: The case for genome-wide affinity reagents. FEBS Lett. 2012; 586(17):2778-9. DOI: 10.1016/j.febslet.2012.05.044. View

16.

Chiu H, Crowe D, Renz M, Presta L, Jones S, Weissman I . Similar but nonidentical amino acid residues on vascular cell adhesion molecule-1 are involved in the interaction with alpha 4 beta 1 and alpha 4 beta 7 under different activity states. J Immunol. 1995; 155(11):5257-67. View

17.

Vonderheide R, Springer T . Lymphocyte adhesion through very late antigen 4: evidence for a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule 1 and an additional alpha 4 integrin counter-receptor on stimulated endothelium. J Exp Med. 1992; 175(6):1433-42. PMC: 2119261. DOI: 10.1084/jem.175.6.1433. View

18.

Otwinowski Z, Minor W . Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997; 276:307-26. DOI: 10.1016/S0076-6879(97)76066-X. View

19.

Kent S, Karlik S, Cannon C, Hines D, Yednock T, Fritz L . A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol. 1995; 58(1):1-10. DOI: 10.1016/0165-5728(94)00165-k. View

20.

ODay K, Meyer K, Miller R, Agarwal S, Franklin M . Cost-effectiveness of natalizumab versus fingolimod for the treatment of relapsing multiple sclerosis. J Med Econ. 2011; 14(5):617-27. DOI: 10.3111/13696998.2011.602444. View